Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Targeting IRE1 endoribonuclease activity alleviates cardiovascular lesions in a murine model of Kawasaki disease vasculitis
Stefanie Marek-Iannucci, Asli D. Yildirim, Syed M. Hamid, Asli B. Ozdemir, Angela C. Gomez, Begüm Kocatürk, Rebecca A. Porritt, Michael C. Fishbein, Takao Iwawaki, Magali Noval Rivas, Ebru Erbay, Moshe Arditi
Stefanie Marek-Iannucci, Asli D. Yildirim, Syed M. Hamid, Asli B. Ozdemir, Angela C. Gomez, Begüm Kocatürk, Rebecca A. Porritt, Michael C. Fishbein, Takao Iwawaki, Magali Noval Rivas, Ebru Erbay, Moshe Arditi
View: Text | PDF
Research Article Immunology Vascular biology

Targeting IRE1 endoribonuclease activity alleviates cardiovascular lesions in a murine model of Kawasaki disease vasculitis

  • Text
  • PDF
Abstract

Kawasaki disease (KD) is the leading cause of noncongenital heart disease in children. Studies in mice and humans propound the NLRP3/IL-1β pathway as the principal driver of KD pathophysiology. Endoplasmic reticulum (ER) stress can activate the NLRP3 inflammasome, but the potential implication of ER stress in KD pathophysiology has not been investigated to our knowledge. We used human patient data and the Lactobacillus casei cell wall extract (LCWE) murine model of KD vasculitis to characterize the impact of ER stress on the development of cardiovascular lesions. KD patient transcriptomics and single-cell RNA sequencing of the abdominal aorta from LCWE-injected mice revealed changes in the expression of ER stress genes. Alleviating ER stress genetically, by conditional deletion of inositol-requiring enzyme 1 (IRE1) in myeloid cells, or pharmacologically, by inhibition of IRE1 endoribonuclease (RNase) activity, led to significant reduction of LCWE-induced cardiovascular lesion formation as well as reduced caspase-1 activity and IL-1β secretion. These results demonstrate the causal relationship of ER stress to KD pathogenesis and highlight IRE1 RNase activity as a potential new therapeutic target.

Authors

Stefanie Marek-Iannucci, Asli D. Yildirim, Syed M. Hamid, Asli B. Ozdemir, Angela C. Gomez, Begüm Kocatürk, Rebecca A. Porritt, Michael C. Fishbein, Takao Iwawaki, Magali Noval Rivas, Ebru Erbay, Moshe Arditi

×

Figure 5

LCWE induces IL-1β and caspase-1 secretion through IRE1.

Options: View larger image (or click on image) Download as PowerPoint
LCWE induces IL-1β and caspase-1 secretion through IRE1.
(A) WT BMDMs we...
(A) WT BMDMs were treated with indicated doses of LCWE for 16 hours. The ER stress inducer tunicamycin (TM) was used as positive control. Protein lysates were analyzed by Western blotting using specific antibodies against p-IRE1 (S747) and ERp57. (B) BMDMs were pretreated with IRE1 kinase inhibitors AMG-18 (3 μM) and KIRA6 (15 μM) and RNase inhibitor 4μ8c (100 μM) for 1 hour and then treated with LCWE (75 μg/mL) for 14 hours along with the inhibitors. The supernatants were analyzed by Western blotting for cleaved caspase-1 (p10) and mature IL-1β. Whole-cell lysates were analyzed by Western blotting using specific antibodies against p-IRE1 (S747), IRE1, and β-actin (n = 3). (C) BMDMs derived from LysMCre+ Ern1Δ/Δ and littermate control Ern1fl/fl mice were treated with indicated doses of LCWE for 16 hours to activate the inflammasome. Supernatants were collected and analyzed by Western blotting for cleaved caspase-1 (p10) and mature IL-1β. Whole-cell lysates were prepared from the cells and analyzed by Western blotting using specific antibodies against IRE1, p-IRE1 (S747), and β-actin (n = 3). (D) Quantitative real-time PCR (qRT-PCR) of sXbp1, Il1b, Il6, and Tnfa transcripts in BMDMs derived from LysMCre+ Ern1Δ/Δ and littermate control Ern1fl/fl mice treated with either PBS or LCWE. **P < 0.01, ***P < 0.001, ****P < 0.0001 by 2-way ANOVA with Tukey’s multiple-comparison test. Casp-1, cleaved caspase-1.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts